Diller, Lawrence,
Bitter Pill. Lawrence Diller. - Psychotherapy Networker, 2005. - SIRS Enduring Issues 2006. Article 66, Health, 1522-323X; .
Articles Contained in SIRS Enduring Issues 2006. Originally Published: Bitter Pill, Jan./Feb. 2005; pp. 56+.
This article discusses the controversial finding by research psychologist Nadine Lambert that the "use of Ritalin, one of the most routinely prescribed drugs for children in America, might contribute to later drug abuse," (PSYCHOTHERAPY NETWORKER) noting that Lambert's study has been largely criticized, rebutted, and dismissed by members of the psychiatry community. The author also proposes that the reason "the National Institute on Drug Abuse (NIDA) has refused funding to Nadine Lambert, either to conduct further follow-up on her subjects or to analyze her current data more closely" is because of "the politics of American psychiatry and the influence of the multibillion-dollar psychopharmacology industry on scientific debates within the field."
1522-323X;
Attention-deficit hyperactivity disorder
Drug abuse
Psychiatry--Research
Psychopharmacology
Ritalin
AC1.S5
050
Bitter Pill. Lawrence Diller. - Psychotherapy Networker, 2005. - SIRS Enduring Issues 2006. Article 66, Health, 1522-323X; .
Articles Contained in SIRS Enduring Issues 2006. Originally Published: Bitter Pill, Jan./Feb. 2005; pp. 56+.
This article discusses the controversial finding by research psychologist Nadine Lambert that the "use of Ritalin, one of the most routinely prescribed drugs for children in America, might contribute to later drug abuse," (PSYCHOTHERAPY NETWORKER) noting that Lambert's study has been largely criticized, rebutted, and dismissed by members of the psychiatry community. The author also proposes that the reason "the National Institute on Drug Abuse (NIDA) has refused funding to Nadine Lambert, either to conduct further follow-up on her subjects or to analyze her current data more closely" is because of "the politics of American psychiatry and the influence of the multibillion-dollar psychopharmacology industry on scientific debates within the field."
1522-323X;
Attention-deficit hyperactivity disorder
Drug abuse
Psychiatry--Research
Psychopharmacology
Ritalin
AC1.S5
050